David W Niesel

Title: David W Niesel: Innovator in Vaccination Technologies

Introduction

David W Niesel is a prominent inventor based in League City, TX (US). He has made significant contributions to the field of vaccination, particularly against enterobacteriaceae bacteria. With a total of 5 patents to his name, Niesel's work is recognized for its innovative approaches to immunization.

Latest Patents

Niesel's latest patents include groundbreaking inventions such as "Methods and compositions for vaccination against or involving enterobacteriaceae bacteria." This invention focuses on using methods and compositions to either prophylactically or therapeutically vaccinate subjects against specific pathogens. It involves the production of an attenuated bacterium from the Enterobacteriaceae family, which has a non-functional lipoprotein, serving as a vaccine or a vector for delivering antigens. Another notable patent is the "Non-antibiotic system for selection of recombinant mycobacteria." This invention provides a Mycobacterium-E. coli shuttle vector that contains sequences coding for a tribrid fusion, which includes the M. leprae 18kDa antigen sequence. This method aims to produce protective immunity in hosts requiring treatment.

Career Highlights

David W Niesel is affiliated with the University of Texas System, where he continues to advance research in vaccination technologies. His work has garnered attention for its potential impact on public health and disease prevention.

Collaborations

Niesel has collaborated with notable colleagues such as Gary R Klimpel and J Scott Moncrief, contributing to the advancement of innovative solutions in the field of immunology.

Conclusion

David W Niesel's contributions to vaccination technologies highlight his role as a leading inventor in the field. His innovative patents and ongoing research efforts continue to pave the way for advancements in disease prevention.